Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-04 18:58:03 UTC |
---|
Update Date | 2021-09-14 15:46:19 UTC |
---|
HMDB ID | HMDB0060763 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 4-Hydroxy duloxetine glucuronide |
---|
Description | 4-Hydroxy duloxetine glucuronide belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 4-Hydroxy duloxetine glucuronide is a metabolite of duloxetine. 4-Hydroxy duloxetine glucuronide is a very strong basic compound (based on its pKa). It is effective for major depressive disorder and generalized anxiety disorder (GAD). Duloxetine (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela) is a serotonin-norepinephrine reuptake inhibitor (SNRI) manufactured and marketed by Eli Lilly. |
---|
Structure | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C2=CC=CC=C12)C1=CC=CS1 InChI=1S/C24H27NO8S/c1-25-11-10-17(18-7-4-12-34-18)31-15-8-9-16(14-6-3-2-5-13(14)15)32-24-21(28)19(26)20(27)22(33-24)23(29)30/h2-9,12,17,19-22,24-28H,10-11H2,1H3,(H,29,30)/t17-,19-,20-,21+,22-,24+/m0/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C24H27NO8S |
---|
Average Molecular Weight | 489.538 |
---|
Monoisotopic Molecular Weight | 489.145737535 |
---|
IUPAC Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({4-[(1S)-3-(methylamino)-1-(thiophen-2-yl)propoxy]naphthalen-1-yl}oxy)oxane-2-carboxylic acid |
---|
Traditional Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({4-[(1S)-3-(methylamino)-1-(thiophen-2-yl)propoxy]naphthalen-1-yl}oxy)oxane-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C2=CC=CC=C12)C1=CC=CS1 |
---|
InChI Identifier | InChI=1S/C24H27NO8S/c1-25-11-10-17(18-7-4-12-34-18)31-15-8-9-16(14-6-3-2-5-13(14)15)32-24-21(28)19(26)20(27)22(33-24)23(29)30/h2-9,12,17,19-22,24-28H,10-11H2,1H3,(H,29,30)/t17-,19-,20-,21+,22-,24+/m0/s1 |
---|
InChI Key | OBIZFSZXDHWUJZ-ANUWOGMRSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Phenolic glycosides |
---|
Alternative Parents | |
---|
Substituents | - Phenolic glycoside
- O-glucuronide
- 1-o-glucuronide
- Glucuronic acid or derivatives
- O-glycosyl compound
- Naphthalene
- Beta-hydroxy acid
- Alkyl aryl ether
- Aralkylamine
- Pyran
- Oxane
- Benzenoid
- Monosaccharide
- Hydroxy acid
- Thiophene
- Heteroaromatic compound
- Amino acid
- Carboxylic acid salt
- Amino acid or derivatives
- Secondary alcohol
- Acetal
- Carboxylic acid derivative
- Carboxylic acid
- Secondary aliphatic amine
- Ether
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Secondary amine
- Polyol
- Organic nitrogen compound
- Amine
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Organic salt
- Organic zwitterion
- Alcohol
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-Hydroxy duloxetine glucuronide,1TMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3866.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3857.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TMS,isomer #3 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3857.7 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TMS,isomer #4 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3830.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TMS,isomer #5 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4031.9 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3834.3 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #10 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3984.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3851.5 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #3 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3848.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #4 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4010.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #5 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3835.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #6 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3849.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #7 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3994.5 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #8 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3828.8 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TMS,isomer #9 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4008.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 3860.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #10 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3990.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3862.5 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #3 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3993.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #4 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3870.7 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #5 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4008.9 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #6 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4011.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #7 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3858.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #8 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3978.7 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TMS,isomer #9 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4002.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,4TMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 3898.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,4TMS,isomer #2 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3981.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,4TMS,isomer #3 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3995.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,4TMS,isomer #4 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4023.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,4TMS,isomer #5 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3980.0 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,5TMS,isomer #1 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4000.8 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,5TMS,isomer #1 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 3721.4 | Standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,5TMS,isomer #1 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C | 4336.3 | Standard polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TBDMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4100.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TBDMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4110.8 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TBDMS,isomer #3 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4107.8 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TBDMS,isomer #4 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4098.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,1TBDMS,isomer #5 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4254.6 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4266.9 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #10 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4455.0 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4267.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #3 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4270.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #4 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4455.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #5 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4259.7 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #6 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4274.0 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #7 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4456.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #8 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4266.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,2TBDMS,isomer #9 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4474.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #1 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1 | 4399.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #10 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4620.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #2 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4422.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #3 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4619.1 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #4 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4409.9 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #5 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4637.2 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #6 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4628.3 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #7 | CNCC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1 | 4396.3 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #8 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4596.4 | Semi standard non polar | 33892256 | 4-Hydroxy duloxetine glucuronide,3TBDMS,isomer #9 | CN(CC[C@H](OC1=CC=C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C2=CC=CC=C12)C1=CC=CS1)[Si](C)(C)C(C)(C)C | 4629.4 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxy duloxetine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9203300000-96e3bcdf2a5a229ec19b | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxy duloxetine glucuronide GC-MS (2 TMS) - 70eV, Positive | splash10-014i-9412045000-8678edfcdae86c38cc12 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxy duloxetine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxy duloxetine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 10V, Positive-QTOF | splash10-03kc-0035900000-d6d0a354712dbb8c3228 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 20V, Positive-QTOF | splash10-03dm-4396100000-2240a8d2b123cf848602 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 40V, Positive-QTOF | splash10-115d-4971000000-58a0eb5eccc49598142f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 10V, Negative-QTOF | splash10-01p9-2215900000-4b7f4a8f9891752c4e4a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 20V, Negative-QTOF | splash10-03di-3339500000-76b4fbf919961e862ff5 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 40V, Negative-QTOF | splash10-08fr-9566000000-0063f46883fefcced025 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 10V, Positive-QTOF | splash10-006x-0101900000-2bce4aee3c71e555e385 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 20V, Positive-QTOF | splash10-01vo-1302900000-09f16a4ed81656601cc6 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 40V, Positive-QTOF | splash10-08fv-1921100000-7a66026c8a80d67b2716 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 10V, Negative-QTOF | splash10-000i-0003900000-27a1110397f6eb3f63f8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 20V, Negative-QTOF | splash10-001i-9203300000-80467d71ad75c0e17110 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxy duloxetine glucuronide 40V, Negative-QTOF | splash10-0a4i-8942100000-d07f203444453f0f04fd | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|